CN103432575B - Composite biological agent for treating neurodermatitis - Google Patents
Composite biological agent for treating neurodermatitis Download PDFInfo
- Publication number
- CN103432575B CN103432575B CN201310398454.4A CN201310398454A CN103432575B CN 103432575 B CN103432575 B CN 103432575B CN 201310398454 A CN201310398454 A CN 201310398454A CN 103432575 B CN103432575 B CN 103432575B
- Authority
- CN
- China
- Prior art keywords
- biological agent
- composite biological
- neurodermatitis
- mucoprotein
- amylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a composite biological agent for treating neurodermatitis. The composite biological agent is prepared by adding inorganic ion sodium, potassium, calcium and chloride ion into organic matter amylase, acid mucopolysaccharide, mucoprotein and lysozyme. The lysozyme in the composite biological agent has the effect of killing morbific bacteria, the amylase, acid mucopolysaccharide and mucoprotein guarantee the standing time of the composite biological agent on the skin and can promote the hardened skin to be softened and resolved, so that the composite biological agent has good curative effect on the neurodermatitis.
Description
Technical field
The invention belongs to medicine manufacture technology field, particularly a kind of external skin medicine.
Background technology
Neurodermatitis is a kind of common chronic skin delayed ischemic neurological deficits dermatoses.Neurodermatitis brings many troubles and misery to the daily life of patient, the health of serious harm people.Violent pruritus, scabies is grabbed incessantly, usually makes people's uneasy in either sitting or lying, and night can not sleep, and daytime can not normally work.Grab owing to scratching for a long time, skin injury, scytitis can be caused to increase the weight of.The course of disease is longer, bad during fashion, does not touchingly heal, and makes patient unhappy, even easy hot-tempered irritability, secondary eczema that What is more and folliculitis or secondary infection other diseases.Long-time morbidity, medication lack of standardization, treatment is not thorough, and can expand gradually, scratching to grab all may affect the attractive in appearance of people, even causes endocrine regulation, has a strong impact on the life of people, and What is more can cause body dysfunction.Some patients is treated thorough for a long time, loses the confidence to the treatment of neurodermatitis, every day crestfallen, lassitude.Spirit can be caused, neurological disorder.Repeatedly scratch and grab, more do not understand all the year round and self send out, form disseminated neurodermatitis, embezzle whole body.Neurodermatitis has hereditary allergic constitution to be inclined to.
At present for the treatment of this disease, Western medicine Duo Shi antihistamine drug chlorphenamine, Cyproheptadine etc. are for oral administration, external corticosteroids ointment or with local block therapy, but all effect is poor.Also have the report adopting treatment by Chinese herbs, but treatment by Chinese herbs is oversize for the course for the treatment of.
Summary of the invention
The present invention seeks to propose a kind of composite biological agent for the treatment of neurodermatitis.
Be used for the treatment of a composite biological agent for neurodermatitis, it is characterized in that by adding inorganic ions sodium in Organic substance amylase, acidic mucopolysaccharide, mucoprotein and lysozyme, potassium, calcium, chloride ion be mixed with.
The described composite biological agent being used for the treatment of neurodermatitis, it is prepared according to following technique: equivalent amylase, acidic mucopolysaccharide, mucoprotein and lysozyme mix with the inorganic matter of trace containing sodium, potassium, calcium, chloride ion, add medicinal film former, PH is to alkalescence in adjustment.
Described film former is pulullan polysaccharide, and inorganic matter adopts sodium chloride, potassium chloride, calcium sulfate.During the present invention adopts, bacteriolyze ferment has killing effect for the Fine bacterium of causing a disease, and amylase, acidic mucopolysaccharide, mucoprotein etc. ensure that the time of staying on skin and promote that sclerosis dermalaxia is decomposed, and has better therapeutic effect for neurodermatitis.
Detailed description of the invention
Be used for the treatment of the composite biological agent of neurodermatitis, it is prepared according to following technique: amylase, acidic mucopolysaccharide, the mucoprotein and each 100 grams of mixing of lysozyme, each 0.5 gram of sodium chloride, potassium chloride, calcium sulfate adds a small amount of water dissolution, adds 10 grams of pulullan polysaccharides and is uniformly mixed and makes paste.
It is as follows that the present invention treats the routine clinical report of neurodermatitis 43.
1, clinical data: 43 examples all derive from inventor's actual therapeutic.Wherein cervical region both sides, cervical region, fossa cubitalis, popliteal nest, sacrococcygeal region, wrist, ankle are many, also have a small amount of lower back, eyelid, extremity position.32 examples are local neurodermatitis; 12 routine generalized neurodermatitises.Age distribution be 16-38 year, male 18 example, women 25 example.
2, diagnostic criteria:
Meet following condition to make a definite diagnosis:
(1). erythra is flat pimple, lichenification, without oozing out.
(2). the course of disease is chronic, normal recurrent exerbation.
3, Therapeutic Method: all patients adopt biological preparation of the present invention to smear affected part, every day sooner or later respectively once.Continuous use one week.
4, standard is treated:
(1) cure: clinical symptom disappearance, and do not recur within half a year.
(2) effective: clinical symptoms has larger improvement.
(3) effective: clinical symptoms alleviates to some extent.
(4) invalid: clinical symptoms is not improved.
5, result statistics: cure 29 examples, effective 7 examples, effective 5 examples, invalid 2 examples.
6, conclusion: the present invention, by biological preparation detoxicating, killing bacteria, reaches 95.3% to neurodermatitis effective percentage., particularly cure rate reaches 67.4%, substantially solve neurodermatitis be difficult to cure problem, and only have the course for the treatment of once week can take effect.
Claims (1)
1. be used for the treatment of a composite biological agent for neurodermatitis, it is characterized in that by adding inorganic ions sodium in Organic substance amylase, acidic mucopolysaccharide, mucoprotein and lysozyme, potassium, calcium, chloride ion be mixed with; And prepare according to following technique: amylase, acidic mucopolysaccharide, the mucoprotein and each 100 grams of mixing of lysozyme, each 0.5 gram of sodium chloride, potassium chloride, calcium sulfate adds a small amount of water dissolution, adds 10 grams of film former pulullan polysaccharides and is uniformly mixed and makes paste.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310398454.4A CN103432575B (en) | 2013-09-05 | 2013-09-05 | Composite biological agent for treating neurodermatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310398454.4A CN103432575B (en) | 2013-09-05 | 2013-09-05 | Composite biological agent for treating neurodermatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103432575A CN103432575A (en) | 2013-12-11 |
| CN103432575B true CN103432575B (en) | 2015-07-01 |
Family
ID=49686357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310398454.4A Expired - Fee Related CN103432575B (en) | 2013-09-05 | 2013-09-05 | Composite biological agent for treating neurodermatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103432575B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102697052A (en) * | 2012-06-18 | 2012-10-03 | 刘春雨 | Starch health-preserving tasty and refreshing tablets |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE970541A1 (en) * | 1997-07-25 | 1999-01-27 | Michael Anthony Folan | Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity |
| CN102919218B (en) * | 2012-11-21 | 2014-03-05 | 湖北维达健基因技术有限公司 | Composite for preservation of human saliva and preparation method thereof |
-
2013
- 2013-09-05 CN CN201310398454.4A patent/CN103432575B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102697052A (en) * | 2012-06-18 | 2012-10-03 | 刘春雨 | Starch health-preserving tasty and refreshing tablets |
Non-Patent Citations (3)
| Title |
|---|
| Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostvmia;G.Regelink et al;《Oral Medicine》;19981231;第29卷(第6期);383-387 * |
| The Efficacy of Mucin-Containing Artificial Saliva in Alleviating Symptoms of Xerostomia;A.VISSINK et al;《Gerodonloloy》;19871231;第6卷(第3期);95-100 * |
| 袁益明.唾液能治皮炎吗.《中国当代妇女百科知识全书》.1997,1404. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103432575A (en) | 2013-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872241A (en) | Traditional Chinese medicinal composition for treating inflammatory dermatosis and preparation thereof | |
| WO2015024420A1 (en) | Local anesthesia pain-relieving time-delay agent | |
| CN103656025B (en) | A kind of medical liquor for treating injury | |
| CN103432575B (en) | Composite biological agent for treating neurodermatitis | |
| CN105030901A (en) | Traditional Chinese medicine composition for treatment of skin diseases and application method thereof | |
| CN102225101B (en) | Traditional Chinese medicine for treating hemorrhoids | |
| CN106266638A (en) | A kind of Chinese medicine preparation treating insomnia and preparation method | |
| CN106880670B (en) | A kind of medicine for treating scabies | |
| CN106177437B (en) | Maca composition for improving yang deficiency and body cold of women | |
| CN101199766B (en) | Medicament for treating epileps | |
| CN101229193A (en) | External Chinese patent medicine for treating skin ulceration and organism gangrene | |
| CN102178851B (en) | Medicament for treating nervous headache | |
| CN103989797B (en) | A kind of Chinese medicine preparation for the treatment of infant eczema | |
| CN104353025A (en) | Foot bath formula for treating constipation | |
| CN105998335A (en) | Tranquilizing traditional Chinese medicine composition gel and preparation method thereof | |
| CN101612361A (en) | A kind of medicine for the treatment of Menieres disease and preparation method thereof | |
| CN104840624A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN103565867A (en) | Medicament for treating late ulcers | |
| CN104784332B (en) | A kind of preparation method of the medicament treating Chronic Urinary Tract Infection | |
| CN104056081A (en) | Traditional Chinese medicine preparation for treating epilepsy | |
| CN1330356C (en) | Traditional Chinese medicine for treating esophague cancer | |
| CN111568990A (en) | Composite medicine for treating allergic and chronic rhinitis and preparation method thereof | |
| CN104524297A (en) | Traditional Chinese medicine for treating kidney-yang insufficiency type allergic rhinitis | |
| CN103006948B (en) | Traditional Chinese medicine acupoint external application magnet therapy paste for treating tourette syndrome | |
| CN100337669C (en) | Externally applied medicine for curing pain and process for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150701 Termination date: 20160905 |